EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hypercapnia at the molecular level: effects on human physiology

L. Kh. Pastushkova, A. G. Goncharova, D. N. Kashirina, I. M. Larina

Frontiers in Physiology · 16.11.2026 · 17

DOI: 10.3389/fphys.2026.2001738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 16.11.2026. Verfasst von L. Kh. Pastushkova und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated carbon dioxide (CO 2 ) levels in both the inspired gas mixture and arterial blood are independently physiologically significant when working in sealed environments, including space exploration. This issue is therefore highly relevant to aerospace medicine, diving medicine, and environmental medicine. Hypercapnia is generally defined as a rise in PaCO 2 (arterial partial pressure of carbon dioxide) above 45 mmHg. It develops due to alveolar hypoventilation, increased dead space, excessive CO 2 production, or exogenous CO 2 intake. The biological effect is mediated by shifts in blood pH and is determined not only by CO 2 concentration but also by the duration of exposure, the rate of PaCO 2 rise, the degree of acidemia, blood O 2 content, physical exertion, temperature, and the baseline status of the respiratory, cardiovascular, and renal systems. Therefore, ambient CO 2 concentration and PaCO 2 cannot be used as interchangeable indicators. The value of a molecular biomarker for hypercapnia lies not only in its correlation with elevated CO 2 levels but also in its potential to reveal episodic or chronic hypercapnia—and, ideally, prior hypercapnic exposure—when direct measurement is not feasible. This review aims to systematize the health risks associated with hypercapnia, outline the temporal sequence of compensatory and deleterious reactions, and identify candidate protein markers or molecular effectors of the CO 2 response for situations in which direct measurement of PaCO 2 is not feasible.

Zitieren

APA

Pastushkova, L. K., Goncharova, A. G., Kashirina, D. N., & Larina, I. M. (2026). Hypercapnia at the molecular level: effects on human physiology. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.2001738

Vancouver

Pastushkova LK, Goncharova AG, Kashirina DN, Larina IM. Hypercapnia at the molecular level: effects on human physiology. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.2001738

BibTeX
@article{Pastushkova2026,
  author = {Pastushkova, L. Kh. and Goncharova, A. G. and Kashirina, D. N. and Larina, I. M.},
  title = {Hypercapnia at the molecular level: effects on human physiology},
  journal = {Frontiers in Physiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphys.2026.2001738}
}
Kostenlos starten →